結核ワクチン治療の世界市場（～2026年）

• 英文タイトル：Global Tuberculosis Vaccine Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04904
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は結核ワクチン治療のグローバル市場について調査・分析したレポートです。種類別（免疫療法ワクチン、ブースターワクチン、その他）市場規模、用途別（病院、診療所、研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別結核ワクチン治療の競争状況、市場シェア
・世界の結核ワクチン治療市場：種類別市場規模 2015年-2020年（免疫療法ワクチン、ブースターワクチン、その他）
・世界の結核ワクチン治療市場：種類別市場規模予測 2021年-2026年（免疫療法ワクチン、ブースターワクチン、その他）
・世界の結核ワクチン治療市場：用途別市場規模 2015年-2020年（病院、診療所、研究所、その他）
・世界の結核ワクチン治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究所、その他）
・北米の結核ワクチン治療市場分析：米国、カナダ
・ヨーロッパの結核ワクチン治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの結核ワクチン治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の結核ワクチン治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの結核ワクチン治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Sanofi、Merck、Serum Institute of India、GlaxoSmithKline、Japan BCG Lab、IDT Biologics、GreenSignal Bio Pharma、Taj Pharmaceuticals、Bavarian Nordic、China National Biotec Group
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
America holds the largest market share of TB vaccines due to the major market players are concentrated and its emphasis on vaccination against TB.

Market Analysis and Insights: Global Tuberculosis Vaccine Treatment Market
The global Tuberculosis Vaccine Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Tuberculosis Vaccine Treatment Scope and Market Size
Tuberculosis Vaccine Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccine Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group

Market segment by Type, the product can be split into
Immunotherapeutic Vaccines
Booster Vaccines
Others
Market segment by Application, split into
Hospitals
Clinics
Research Institutes
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tuberculosis Vaccine Treatment Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunotherapeutic Vaccines
1.4.3 Booster Vaccines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Tuberculosis Vaccine Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Tuberculosis Vaccine Treatment Market Perspective (2015-2026)
2.2 Global Tuberculosis Vaccine Treatment Growth Trends by Regions
2.2.1 Tuberculosis Vaccine Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tuberculosis Vaccine Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tuberculosis Vaccine Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tuberculosis Vaccine Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Tuberculosis Vaccine Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Vaccine Treatment Players by Market Size
3.1.1 Global Top Tuberculosis Vaccine Treatment Players by Revenue (2015-2020)
3.1.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tuberculosis Vaccine Treatment Market Concentration Ratio
3.2.1 Global Tuberculosis Vaccine Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Treatment Revenue in 2019
3.3 Tuberculosis Vaccine Treatment Key Players Head office and Area Served
3.4 Key Players Tuberculosis Vaccine Treatment Product Solution and Service
3.5 Date of Enter into Tuberculosis Vaccine Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Vaccine Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
5.2 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Tuberculosis Vaccine Treatment Market Size (2015-2020)
6.2 Tuberculosis Vaccine Treatment Key Players in North America (2019-2020)
6.3 North America Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
6.4 North America Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Tuberculosis Vaccine Treatment Market Size (2015-2020)
7.2 Tuberculosis Vaccine Treatment Key Players in Europe (2019-2020)
7.3 Europe Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
7.4 Europe Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

8 China
8.1 China Tuberculosis Vaccine Treatment Market Size (2015-2020)
8.2 Tuberculosis Vaccine Treatment Key Players in China (2019-2020)
8.3 China Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
8.4 China Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Tuberculosis Vaccine Treatment Market Size (2015-2020)
9.2 Tuberculosis Vaccine Treatment Key Players in Japan (2019-2020)
9.3 Japan Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
9.4 Japan Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Tuberculosis Vaccine Treatment Market Size (2015-2020)
10.2 Tuberculosis Vaccine Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

11 India
11.1 India Tuberculosis Vaccine Treatment Market Size (2015-2020)
11.2 Tuberculosis Vaccine Treatment Key Players in India (2019-2020)
11.3 India Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
11.4 India Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Tuberculosis Vaccine Treatment Market Size (2015-2020)
12.2 Tuberculosis Vaccine Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Tuberculosis Vaccine Treatment Introduction
13.1.4 Sanofi Revenue in Tuberculosis Vaccine Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Tuberculosis Vaccine Treatment Introduction
13.2.4 Merck Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Details
13.3.2 Serum Institute of India Business Overview
13.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Introduction
13.3.4 Serum Institute of India Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.3.5 Serum Institute of India Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Tuberculosis Vaccine Treatment Introduction
13.4.4 GlaxoSmithKline Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Japan BCG Lab
13.5.1 Japan BCG Lab Company Details
13.5.2 Japan BCG Lab Business Overview
13.5.3 Japan BCG Lab Tuberculosis Vaccine Treatment Introduction
13.5.4 Japan BCG Lab Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.5.5 Japan BCG Lab Recent Development
13.6 IDT Biologics
13.6.1 IDT Biologics Company Details
13.6.2 IDT Biologics Business Overview
13.6.3 IDT Biologics Tuberculosis Vaccine Treatment Introduction
13.6.4 IDT Biologics Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.6.5 IDT Biologics Recent Development
13.7 GreenSignal Bio Pharma
13.7.1 GreenSignal Bio Pharma Company Details
13.7.2 GreenSignal Bio Pharma Business Overview
13.7.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Introduction
13.7.4 GreenSignal Bio Pharma Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.7.5 GreenSignal Bio Pharma Recent Development
13.8 Taj Pharmaceuticals
13.8.1 Taj Pharmaceuticals Company Details
13.8.2 Taj Pharmaceuticals Business Overview
13.8.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Introduction
13.8.4 Taj Pharmaceuticals Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.8.5 Taj Pharmaceuticals Recent Development
13.9 Bavarian Nordic
13.9.1 Bavarian Nordic Company Details
13.9.2 Bavarian Nordic Business Overview
13.9.3 Bavarian Nordic Tuberculosis Vaccine Treatment Introduction
13.9.4 Bavarian Nordic Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.9.5 Bavarian Nordic Recent Development
13.10 China National Biotec Group
13.10.1 China National Biotec Group Company Details
13.10.2 China National Biotec Group Business Overview
13.10.3 China National Biotec Group Tuberculosis Vaccine Treatment Introduction
13.10.4 China National Biotec Group Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.10.5 China National Biotec Group Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Tuberculosis Vaccine Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Tuberculosis Vaccine Treatment Revenue
Table 3. Ranking of Global Top Tuberculosis Vaccine Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunotherapeutic Vaccines
Table 6. Key Players of Booster Vaccines
Table 7. Key Players of Others
Table 8. Global Tuberculosis Vaccine Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Tuberculosis Vaccine Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Tuberculosis Vaccine Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Tuberculosis Vaccine Treatment Market Share by Regions (2015-2020)
Table 12. Global Tuberculosis Vaccine Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Tuberculosis Vaccine Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Tuberculosis Vaccine Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Tuberculosis Vaccine Treatment Players
Table 19. Global Tuberculosis Vaccine Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Tuberculosis Vaccine Treatment Market Share by Players (2015-2020)
Table 21. Global Top Tuberculosis Vaccine Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccine Treatment as of 2019)
Table 22. Global Tuberculosis Vaccine Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Tuberculosis Vaccine Treatment Product Solution and Service
Table 25. Date of Enter into Tuberculosis Vaccine Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tuberculosis Vaccine Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Tuberculosis Vaccine Treatment Market Size Share by Type (2015-2020)
Table 29. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Tuberculosis Vaccine Treatment Market Size Share by Application (2015-2020)
Table 31. Global Tuberculosis Vaccine Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Tuberculosis Vaccine Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Tuberculosis Vaccine Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Tuberculosis Vaccine Treatment Market Share (2019-2020)
Table 35. North America Tuberculosis Vaccine Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Tuberculosis Vaccine Treatment Market Share by Type (2015-2020)
Table 37. North America Tuberculosis Vaccine Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Tuberculosis Vaccine Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Tuberculosis Vaccine Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Tuberculosis Vaccine Treatment Market Share (2019-2020)
Table 41. Europe Tuberculosis Vaccine Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Tuberculosis Vaccine Treatment Market Share by Type (2015-2020)
Table 43. Europe Tuberculosis Vaccine Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Tuberculosis Vaccine Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Tuberculosis Vaccine Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Tuberculosis Vaccine Treatment Market Share (2019-2020)
Table 47. China Tuberculosis Vaccine Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Tuberculosis Vaccine Treatment Market Share by Type (2015-2020)
Table 49. China Tuberculosis Vaccine Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Tuberculosis Vaccine Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Tuberculosis Vaccine Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Tuberculosis Vaccine Treatment Market Share (2019-2020)
Table 53. Japan Tuberculosis Vaccine Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Tuberculosis Vaccine Treatment Market Share by Type (2015-2020)
Table 55. Japan Tuberculosis Vaccine Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Tuberculosis Vaccine Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Tuberculosis Vaccine Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Tuberculosis Vaccine Treatment Market Share (2019-2020)
Table 59. Southeast Asia Tuberculosis Vaccine Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Tuberculosis Vaccine Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Tuberculosis Vaccine Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Tuberculosis Vaccine Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Tuberculosis Vaccine Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Tuberculosis Vaccine Treatment Market Share (2019-2020)
Table 65. India Tuberculosis Vaccine Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Tuberculosis Vaccine Treatment Market Share by Type (2015-2020)
Table 67. India Tuberculosis Vaccine Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Tuberculosis Vaccine Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Tuberculosis Vaccine Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Tuberculosis Vaccine Treatment Market Share (2019-2020)
Table 71. Central & South America Tuberculosis Vaccine Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Tuberculosis Vaccine Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Tuberculosis Vaccine Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Tuberculosis Vaccine Treatment Market Share by Application (2015-2020)
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Product
Table 78. Sanofi Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 79. Sanofi Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Product
Table 83. Merck Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 84. Merck Recent Development
Table 85. Serum Institute of India Company Details
Table 86. Serum Institute of India Business Overview
Table 87. Serum Institute of India Product
Table 88. Serum Institute of India Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 89. Serum Institute of India Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Japan BCG Lab Company Details
Table 96. Japan BCG Lab Business Overview
Table 97. Japan BCG Lab Product
Table 98. Japan BCG Lab Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 99. Japan BCG Lab Recent Development
Table 100. IDT Biologics Company Details
Table 101. IDT Biologics Business Overview
Table 102. IDT Biologics Product
Table 103. IDT Biologics Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 104. IDT Biologics Recent Development
Table 105. GreenSignal Bio Pharma Company Details
Table 106. GreenSignal Bio Pharma Business Overview
Table 107. GreenSignal Bio Pharma Product
Table 108. GreenSignal Bio Pharma Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 109. GreenSignal Bio Pharma Recent Development
Table 110. Taj Pharmaceuticals Business Overview
Table 111. Taj Pharmaceuticals Product
Table 112. Taj Pharmaceuticals Company Details
Table 113. Taj Pharmaceuticals Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 114. Taj Pharmaceuticals Recent Development
Table 115. Bavarian Nordic Company Details
Table 116. Bavarian Nordic Business Overview
Table 117. Bavarian Nordic Product
Table 118. Bavarian Nordic Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 119. Bavarian Nordic Recent Development
Table 120. China National Biotec Group Company Details
Table 121. China National Biotec Group Business Overview
Table 122. China National Biotec Group Product
Table 123. China National Biotec Group Revenue in Tuberculosis Vaccine Treatment Business (2015-2020) (Million US$)
Table 124. China National Biotec Group Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Vaccine Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immunotherapeutic Vaccines Features
Figure 3. Booster Vaccines Features
Figure 4. Others Features
Figure 5. Global Tuberculosis Vaccine Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Tuberculosis Vaccine Treatment Report Years Considered
Figure 11. Global Tuberculosis Vaccine Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Tuberculosis Vaccine Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Tuberculosis Vaccine Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Tuberculosis Vaccine Treatment Market Share by Players in 2019
Figure 16. Global Top Tuberculosis Vaccine Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccine Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis Vaccine Treatment Revenue in 2019
Figure 18. North America Tuberculosis Vaccine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Tuberculosis Vaccine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Tuberculosis Vaccine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Tuberculosis Vaccine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Tuberculosis Vaccine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Tuberculosis Vaccine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Tuberculosis Vaccine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

結核治療の世界市場（～2026年）

Global Tuberculosis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04903 2020年11月20日 92Pages
当調査資料は結核治療のグローバル市場について調査・分析したレポートです。種類別（活動性結核、潜在性結核）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、...

結核診断・治療の世界市場（～2026年）

Global Tuberculosis Diagnosis and Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04902 2020年11月20日 134Pages
当調査資料は結核診断・治療のグローバル市場について調査・分析したレポートです。種類別（臨床検査、核酸検査、マントー検査、X線撮影、薬剤感受性検査）市場規模、用途別（病院、政府機関、個人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

結核治療薬の世界市場（～2026年）

Global Tuberculosis Treatment Drugs Market Insights and Forecast to 2026
MRC2-11QY12758 2020年11月25日 112Pages
当調査資料は結核治療薬のグローバル市場について調査・分析したレポートです。種類別（活動性結核、潜在性結核）市場規模、用途別（病院、診療所、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南...

結核（TB）診断の世界市場（～2026年）

Global Tuberculosis (TB) Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY04901 2020年11月20日 96Pages
当調査資料は結核（TB）診断のグローバル市場について調査・分析したレポートです。種類別（塗抹顕微鏡検査、分子検査、マントーツベルクリン検査、培養、薬剤感受性検査、PLHIV用LF-LAM）市場規模、用途別（診断研究所、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

抗結核治療薬の世界市場（～2026年）

Global Tuberculosis Drug Market Insights and Forecast to 2026
MRC2-11QY12757 2020年11月25日 119Pages
当調査資料は抗結核治療薬のグローバル市場について調査・分析したレポートです。種類別（一次抗結核薬、二次抗結核薬）市場規模、用途別（活動性結核、潜在性結核）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、...

mRNAワクチンの世界市場（～2026年）

Global mRNA Vaccine Market Insights and Forecast to 2026
MRC2-11QY07910 2020年11月20日 110Pages
当調査資料はmRNAワクチンのグローバル市場について調査・分析したレポートです。種類別（がん治療標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）市場規模、用途別（感染症、がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

結核ワクチンの世界市場（～2026年）

Global Tuberculosis Vaccines Market Insights and Forecast to 2026
MRC2-11QY12759 2020年11月25日 113Pages
当調査資料は結核ワクチンのグローバル市場について調査・分析したレポートです。種類別（免疫療法ワクチン、ブースターワクチン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

ニューカッスル病治療の世界市場（～2026年）

Global Newcastle Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03968 2020年11月20日 99Pages
当調査資料はニューカッスル病治療のグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

子宮頸がんワクチンの世界市場（～2026年）

Global Cervical Cancer Vaccine Market Insights and Forecast to 2026
MRC2-11QY00119 2020年11月20日 113Pages
当調査資料は子宮頸がんワクチンのグローバル市場について調査・分析したレポートです。種類別（2価ワクチン、4価ワクチン）市場規模、用途別（年齢（9-25）、年齢（20-45））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

アデノウイルスワクチンの世界市場（～2026年）

Global Adenovirus Vaccine Market Insights and Forecast to 2026
MRC2-11QY02092 2020年11月20日 115Pages
当調査資料はアデノウイルスワクチンのグローバル市場について調査・分析したレポートです。種類別（タイプ4ワクチン、タイプ7ワクチン）市場規模、用途別（研究所・学術研究所、製薬・バイオテクノロジー企業、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

結核治療の世界市場（～2026年） Market Analysis and Insights: Global Tuberculosis Treatment Market The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tuberculosis Treatment Scope and Market Size Tuberculosis Treatment m…
結核ワクチンの世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
結核診断・治療の世界市場（～2026年） An infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. The rising screening rate in the high burden regions, faster clinical decisions, and affordability of d…
結核治療薬の世界市場（～2026年） Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes, or talks. Market Analysis and Insight…
結核（TB）診断の世界市場（～2026年） Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of lat…